Report Store | Pharma intelligence
  • My Account
    • 0Shopping Cart
  • $0.00
  • Disease analysis
    • Anemias
    • Bacterial infections
    • Bleeding disorders
    • Brain Cancer
    • Breast and gynecological cancer
    • Cardiovascular and Metabolic
    • Central Nervous System
    • Cerebrovascular diseases
    • Dermatology
    • Diabetes and diabetic complications
    • Gastroenterology
    • Gastrointestinal cancer
    • Head and Neck Cancer
    • Hypertension
    • Immunology and Inflammation
    • Infectious Diseases
    • Ischemic heart disease
    • Leukemia
    • Lung Cancer
    • Lymphoma
    • Oncology overview
    • Market Spotlight
    • Mens Health
    • Neurology
    • Oncology
    • Ophthalmology
    • Other Hematological Cancers
    • Other metabolic diseases
    • Other Solid Cancers
    • Pain
    • Psychiatry
    • Respiratory
    • Rheumatology
    • Skin cancer
    • Thrombosis
    • Urological cancer
    • Vaccines
    • Viral infections
    • Women’s Health
  • Strategy analysis
    • Bleeding disorders
    • Breast and gynecological cancer
    • Cardiovascular and Metabolic
    • Central Nervous System
    • Commercial Strategy
    • Dealmaking and R&D
    • Head and Neck Cancer
    • Hot Topics
    • Infectious Diseases
    • KOL Insight
    • Leukemia
    • Lung Cancer
    • Manufacturing
    • Market Access
    • Neurology
    • Oncology
    • Outsourcing
    • Pricing & Reimbursement
    • R&D
    • Regulatory & Therapeutic Area
    • Trends
    • Urological cancer
  • Company analysis
    • Big Pharma
    • Emerging Pharma
    • Hot Topics
    • Japan Pharma
    • M&A Analysis
    • Mid Pharma
  • Drug analysis
    • A
    • B-C
    • D-F
    • G-L
    • M-O
    • P-R
    • S-T
    • U-Z
  • MedTech analysis
    • Allergy
    • Autoimmune / Immunology
    • Cardiovascular
    • Dermatology
    • Endocrine
    • ENT / Dental
    • Gastroenterology
    • Hearing
    • Hematology
    • Infectious Diseases
    • Metabolic
    • Neurology
    • Obstetrics / Gynecology
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Osteoporosis
    • Psychiatry
    • Renal
    • Respiratory
    • Rheumatology
    • Urology
  • Opinion & analysis
    • Business Development
    • Business Management
    • Clinical Trials
    • Digital Health
    • Cybersecurity
    • Compliance & Risk
    • Digital patient management
    • Digital policy & regulation
    • Finance & Pricing
    • Healthcare Innovation
    • ICT and Health
    • Leadership
    • Legislation Regulation & Policy
    • Market Access
    • Market Intelligence
    • Medical
    • Pharmaceutical Device
    • Pharmaceutical Research
    • Strategy & Innovation
    • Tech companies & Data
    • Tech & Pharma
  • Blogs
  • Search
  • Menu
You are here: Home > MedTech analysis

MedTech analysis


loader
  • Sort by Random
    • Default
    • Custom
    • Name
    • Price
    • Date
    • Popularity (sales)
    • Average rating
    • Relevance
    • Random
    • Product ID
  • Display 15 Products per page
    • 15 Products per page
    • 30 Products per page
    • 45 Products per page
  • Global Market for Fracture Fixation Devices

    $4,750.00

    This Meddevicetracker report provides an analysis of the market for fracture fixation devices, including external fixation and internal fixation devices. Geographic segments covered include the US, five major EU markets, Japan, and the rest of the world.The global fracture fixation devices market is expected to increase at a CAGR of 5.9% over the five-year forecast period, reaching nearly $11bn in 2023. Competition is increasing in fracture fixation, as major orthopedic suppliers enter the  market to take advantage of cross-selling opportunities, and manufacturers from other specialties, such as arthroscopy and spine, launch new products.

    August 28, 2019
    Find out more
  • Prostate Cancer Diagnostics and Minimally Invasive Treatments Market

    Prostate Cancer Diagnostics and Minimally Invasive Treatments Market

    $4,750.00

    This comprehensive medical market and technology report provides an overview and in-depth market analysis of selected next-generation prostate cancer diagnostics, biopsy, and minimally invasive treatments.

    May 4, 2022
    Find out more
  • Biomedtracker / Meddevicetracker Q2 2021 Outlook Report

    $4,750.00

    In this report, we cover catalysts from 28 drugs, devices, diagnostics, and deals expected to occur in early 2021. For each drug, the likelihood of Phase/PDUFA review success and overall Likelihood of Approval (LOA) given their particular phase, drug class, and disease group are provided. These data points were provided using a combination of Pharmapremia, Informa’s drug development benchmarking product utilizing Biomedtracker’s LOA data to assist in informed decisions about drug pipeline prioritization, partnerships, and acquisitions, and drug approval data from Biomedtracker.

    April 1, 2021
    Find out more
  • Interventional Cardiology: Atherectomy and Thromboembolectomy

    $4,750.00

    The global market for atherectomy and thromboembolectomy products is anticipated to see moderate, single-digit growth throughout the forecast period covered by this analysis (2016-22). Growth in unit sales is being driven by the increasing prevalence of cardiovascular disease, which is the leading cause of death globally, responsible for over 17 million deaths annually.

    April 5, 2018
    Find out more
  • Drug Delivery: Infusion Devices – August 2020

    $4,750.00

    This report provides a discussion of current/forecast markets, competitors, and opportunities in the global infusion drug delivery devices market, including the volumetric, syringe, ambulatory, disposable, implantable, and enteral pumps segments. Geographic regions covered include the US, five major European markets, Japan, and Rest of World markets; the forecast period is from 2019–24.

    August 14, 2020
    Find out more
  • Diagnostic Electrocardiograph Products

    $4,750.00

    The global market for diagnostic electrocardiograph products is anticipated to see high, single-digit growth throughout the forecast period covered by this analysis (2017-22). Growth in unit sales is being driven by the increasing prevalence of cardiovascular disease, which is the leading cause of death globally, responsible for over 17 million deaths annually.

    June 7, 2018
    Find out more
  • Biomedtracker / Meddevicetracker Q3 2020 Outlook Report

    $4,750.00

    In this report, we cover catalysts from 27 drugs, devices, diagnostics and deals expected to occur in Q3 2020. For each drug, the likelihood of Phase/PDUFA review success and overall Likelihood of Approval (LOA) given their particular phase, drug class, and disease group are provided.

    July 1, 2020
    Find out more
  • U.S. Markets for Critical Care Patient Management Products

    $4,750.00

    This dynamic new report from Medtech Insight includes analyses of products, current/forecast markets, competitors, and opportunities in the U.S. market for critical care patient management products.

    September 22, 2016
    Find out more
  • ECLIPSE Psoriasis Pulse Survey

    $599.00

    This 11-question pulse survey of 74 dermatologists practicing throughout the US and Europe asks respondents their thoughts on results from the ECLIPSE study

    January 31, 2019
    Find out more
  • Identifying High-Growth Medical Technology Markets in SE Asia to 2023

    $2,995.00

    China is such a dominant player in Asia that often time valuable markets of opportunity get ovelooked. This 154 page report provides a detailed statistical view of 10 significant medical device and technology markets in South East Asia worth £14 billion in 2019. Comprising a pdf report and data set in MS Excel™, the report is rich in stats, tables and graphs and covers market value, market growth in US$/local currency and per capita spending over the last 5 years with 5-year forecasts to 2023, a range of demographic and commercial indicators plus analysis of trade segments such as orthopaedic products, medical/surgical consumables and diagnostic imaging.

    August 28, 2019
    Find out more
  • Joint Replacement Implants

    $4,750.00

    The global market for joint replacement implants, which includes prostheses for the hips, knees, shoulders, elbows, ankles, and small joints, totaled nearly $16.4bn in 2017. This market is projected to increase at a compound annual growth rate of 3.8%, reaching nearly $19.8bn in 2022.

    July 31, 2018
    Find out more
  • 2019 ASH Pulse Survey

    $599.00

    This 8-question Pulse survey of 55 hematologic oncologists practicing throughout the United States and Europe asks respondents their thoughts on several topics presented at the 2019 American Society of Hematology (ASH) Annual Meeting. Survey questions and additional resources are listed further below.

    January 10, 2020
    Find out more
  • Cochlear Implants Market

    $4,750.00

    This report includes: an overview of hearing loss, cochlear implant technology, competition, trends, and market analysis. Market analysis includes 5-year market forecast by region, market drivers/limiters, global market share and market share by region.

    February 28, 2019
    Find out more
  • PD-1/L1 Immunotherapies: Historical Sales and Market Trend Analysis Report

    $7,500.00

    Bristol-Myers Squibb’s (BMS) Opdivo (nivolumab) has outpaced Merck’s Keytruda (pembrolizumab) primarily
    in non-small cell lung cancer (NSCLC) because of its early approval in squamous NSCLC, updated National
    Comprehensive Cancer Network (NCCN) guidelines in 2015,

    December 22, 2016
    Find out more
  • France, Disease Incidence and Prevalence

    $4,850.00

    As the aging population in Europe increases and the average life span lengthens, the incidence and prevalence of many major diseases/disorders are expected to increase accordingly and significantly impact the European healthcare industry.

     

    September 22, 2016
    Find out more
Page 3 of 13
Page 3 of 13‹12345›»
  • Home
  • Terms and Conditions
  • Refund policy
  • Privacy Policy
  • Cookie Policy
  • Contact Us
  • About Us
  • Discounts
  • Market Spotlight – Reports
  • twitter
  • linkedin
  • Sitemap
Datamonitor Healthcare is part of Pharma intelligence Datamonitor Healthcare is a trading division of Datamonitor Limited, a company registered in England and Wales with company number 2306113 whose registered office is 5 Howick Place, London, SW1P 1WG. VAT GB365462636. Datamonitor Limited is part of Informa PLC.

Sign up to the Pharma Intelligence Report Store Newsletter to get the latest blogs, news, reports and discounts!

Pharma Intelligence is part of the Business Intelligence Division of Informa PLC
  • Informa PLC
  • ABOUT US
  • INVESTOR RELATIONS
  • TALENT
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726
informa
Call Back
Scroll to top